TipRanks
CSAM Health Group AS (DE:6Q1)
FRANKFURT:6Q1
Germany Market
6Q1
CSAM Health Group AS
RESEARCH TOOLSreports

CSAM Health Group AS (6Q1) Ratios

0 Followers

CSAM Health Group AS Ratios

DE:6Q1's free cash flow for Q2 2026 was kr0.26. For the 2026 fiscal year, DE:6Q1's free cash flow was decreased by kr and operating cash flow was kr0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.65 0.78 0.82 1.31 1.96
Quick Ratio
 0.65 0.78 0.82 1.31 1.96
Cash Ratio
 0.17 0.36 0.46 0.70 1.33
Solvency Ratio
 0.05 0.09 -0.01 0.26 -0.06
Operating Cash Flow Ratio
 0.27 0.12 0.52 0.23 0.08
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr -610.35Mkr -596.71Mkr -559.38Mkr -454.50Mkr -382.41M
Leverage Ratios
Debt-to-Assets Ratio
 0.68 0.61 0.61 0.62 0.71
Debt-to-Equity Ratio
 -24.39 18.33 28.33 5.01 17.18
Debt-to-Capital Ratio
 1.04 0.95 0.97 0.83 0.95
Long-Term Debt-to-Capital Ratio
 1.04 0.95 0.97 0.83 0.95
Financial Leverage Ratio
 -35.70 30.19 46.20 8.08 24.10
Debt Service Coverage Ratio
 1.36 1.68 0.82 4.44 -0.04
Interest Coverage Ratio
 0.92 0.79 -0.20 2.42 -2.01
Debt to Market Cap
 0.55 0.52 0.71 0.63 0.62
Interest Debt Per Share
 26.95 26.85 26.51 25.98 25.35
Net Debt to EBITDA
 4.88 3.52 7.74 1.58 -47.46
Profitability Margins
Gross Profit Margin
57.51%22.95%92.70%92.20%90.90%
EBIT Margin
5.56%9.85%-2.09%38.13%-27.04%
EBITDA Margin
18.87%23.30%11.11%55.52%-1.74%
Operating Profit Margin
11.25%9.85%-2.84%31.35%-20.39%
Pretax Profit Margin
-4.19%3.68%-16.33%25.18%-37.18%
Net Profit Margin
-6.43%1.34%-15.70%25.42%-35.89%
Continuous Operations Profit Margin
-6.43%1.34%-15.70%27.22%-35.89%
Net Income Per EBT
153.54%36.32%96.18%100.95%96.53%
EBT Per EBIT
-37.23%37.37%574.32%80.33%182.37%
Return on Assets (ROA)
-4.45%0.82%-8.47%13.57%-18.97%
Return on Equity (ROE)
-659.89%24.78%-391.31%109.55%-457.37%
Return on Capital Employed (ROCE)
10.76%8.53%-2.27%21.39%-13.60%
Return on Invested Capital (ROIC)
10.76%3.10%-2.19%21.39%-13.13%
Return on Tangible Assets
-17.80%3.00%-26.29%39.86%-40.93%
Earnings Yield
-3.59%0.70%-9.86%13.81%-16.52%
Efficiency Ratios
Receivables Turnover
 5.16 5.05 6.78 6.44 4.06
Payables Turnover
 12.66 24.31 1.27 1.78 2.90
Inventory Turnover
 0.00 7.93K 121.69 681.06 102.08
Fixed Asset Turnover
 86.41 74.26 48.14 44.53 40.13
Asset Turnover
 0.69 0.61 0.54 0.53 0.53
Working Capital Turnover Ratio
 -7.04 -10.14 122.01 4.32 1.95
Cash Conversion Cycle
 41.93 57.36 -230.06 -148.36 -32.37
Days of Sales Outstanding
 70.75 72.33 53.84 56.69 89.82
Days of Inventory Outstanding
 0.00 0.05 3.00 0.54 3.58
Days of Payables Outstanding
 28.82 15.02 286.90 205.58 125.77
Operating Cycle
 70.75 72.37 56.84 57.22 93.40
Cash Flow Ratios
Operating Cash Flow Per Share
 2.60 1.40 6.45 1.91 0.55
Free Cash Flow Per Share
 1.50 1.31 4.30 -0.36 -1.44
CapEx Per Share
 1.10 0.09 2.15 2.27 2.00
Free Cash Flow to Operating Cash Flow
 0.58 0.94 0.67 -0.19 -2.60
Dividend Paid and CapEx Coverage Ratio
 1.64 15.72 2.46 0.84 0.28
Capital Expenditure Coverage Ratio
 2.37 15.72 3.00 0.84 0.28
Operating Cash Flow Coverage Ratio
 0.11 0.06 0.27 0.08 0.02
Operating Cash Flow to Sales Ratio
 0.11 0.06 0.31 0.09 0.03
Free Cash Flow Yield
3.46%2.84%13.04%-0.98%-3.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -27.86 144.06 -10.15 7.24 -6.05
Price-to-Sales (P/S) Ratio
 1.79 1.91 1.59 1.84 2.17
Price-to-Book (P/B) Ratio
 -44.23 35.45 39.69 7.93 27.69
Price-to-Free Cash Flow (P/FCF) Ratio
 28.92 35.27 7.67 -101.57 -26.37
Price-to-Operating Cash Flow Ratio
 16.73 33.02 5.12 19.42 68.48
Price-to-Earnings Growth (PEG) Ratio
 0.03 -1.31 0.06 -0.04 -0.13
Price-to-Fair Value
 -44.23 35.45 39.69 7.93 27.69
Enterprise Value Multiple
 14.38 11.73 22.08 4.90 -172.40
Enterprise Value
 1.35B 1.35B 1.04B 1.12B 1.10B
EV to EBITDA
 14.38 11.73 22.08 4.90 -172.40
EV to Sales
 2.71 2.73 2.45 2.72 3.00
EV to Free Cash Flow
 43.78 50.38 11.82 -150.01 -36.38
EV to Operating Cash Flow
 25.33 47.17 7.88 28.68 94.49
Tangible Book Value Per Share
 -27.32 -27.21 -25.21 -20.18 -16.37
Shareholders’ Equity Per Share
 -0.98 1.30 0.83 4.66 1.37
Tax and Other Ratios
Effective Tax Rate
 -0.54 0.64 0.04 -0.08 0.03
Revenue Per Share
 24.28 24.10 20.72 20.10 17.49
Net Income Per Share
 -1.56 0.32 -3.25 5.11 -6.28
Tax Burden
 1.54 0.36 0.96 1.01 0.97
Interest Burden
 -0.75 0.37 7.82 0.66 1.38
Research & Development to Revenue
 0.00 0.00 0.02 0.00 0.00
SG&A to Revenue
 0.07 0.04 0.05 0.05 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -1.59 4.33 -1.91 0.38 -0.09
Currency in NOK